Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
500 participants
OBSERVATIONAL
2018-05-14
2022-06-23
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
A first clinical study (n=106 patients) confirmed these excellent mechanical results with serial OCT analysis and demonstrated an excellent short term safety. Since 2017, rePOT is recommended in Europe in clinical practice.
This large registry is dedicated to confirm the clinical benefits at long term after bifurcation revascularization with rePOT technique before a large randomise trial.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparison of Results Achieved by Different Ballooning Techniques in Bifurcation Stenting
NCT05559424
Comparison Between Provisional Versus Routine Kissing Balloon Technique After Main Vessel Crossover Stenting for Bifurcated Lesions.
NCT01238510
Treatment of Coronary Bifurcation Lesions: Comparing Reverse T and Protrusion Versus Double-kissing and Crush Stenting
NCT03714750
Keep bIfurcation Single Stenting Simple
NCT04285372
Optimal Strategy to Correct Stent underexpAnsion in Resistant Lesions
NCT07316504
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Provisional stenting with rePOT technique
All revascularizations have to be performed with complete rePOT technique: initial POT + side branch inflation + final POT. Compliant or semi compliant balloon have to be preferred to inflations. The POT balloon positioning have to be precise as obtain the loose of the parallelism just at the carina cut plan. The rest of the medication or procedure characteristics stay at the discretion of the operator.
The follow-up will be clinic every years.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Stable lesion without high thrombus burden
* Patient agreement to study participation and ≥ 18 years
Exclusion Criteria
* Contraindication to a double platelet anti-aggregation ≥ 6mois (recommended implantation of active stent)
* Unstable patient according to the operator (used of hemodynamic drug support, mechanical ventilation)
* Indication of cardiac surgery.
* Lesion culprit in ST- or non ST-elevation myocardial infarction \<12h.
* High thrombus burden in angiography or endocoronary imaging (IVUS, OCT).
* Pregnancy, loose of legal right
* Other interventional study participation \<30 jours.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hospices Civils de Lyon
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Département de cardiologie Clinique Axium
Aix-en-Provence, , France
Fédération de cardiologie médicale - Hôpital Cardiologique Louis Pradel - Hospices civils de Lyon
Bron, , France
Département de cardiologie Hôpital Gabriel Montpied CHU de Clermont Ferrand
Clermont-Ferrand, , France
Département de cardiologie CHU de Nimes
Nîmes, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
69HCL17_0877
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.